Keyphrases
Randomized Controlled Trial
100%
Isolation Method
100%
Distal Pancreatectomy
100%
Study within a Trial
100%
Conventional Procedures
100%
Pancreatic Ductal Adenocarcinoma
66%
Pancreatic Body
66%
Spleen
50%
Distal Pancreatosplenectomy
50%
Pancreas
33%
Splenic Vein
33%
Intraoperative Blood Loss
33%
R0 Resection Rate
33%
Regional Lymph Nodes
33%
Splenic Artery
33%
Before Surgery
16%
Patient Survival
16%
Transection
16%
No Significant Difference
16%
Overall Survival
16%
Connective Tissue
16%
Pancreaticoduodenectomy
16%
Blood Flow
16%
Lymph Node
16%
Bifurcation
16%
Trial Registration
16%
Clinical Trial Registry
16%
Recurrence-free Survival
16%
Celiac Axis
16%
Oncologic
16%
High-volume Center
16%
Intention-to-treat Analysis
16%
Lymph Node Dissection
16%
Lymph Node Ratio
16%
Radical Antegrade Modular Pancreatosplenectomy (RAMPS)
16%
Complete Clearance
16%
Retroperitoneal Dissection
16%
Method Design
16%
Lymph Flow
16%
Medicine and Dentistry
Arm
100%
Pancreas Adenocarcinoma
100%
Tail
100%
Randomized Controlled Trial
100%
Distal Pancreatectomy
100%
Artery
75%
Lymph Node
75%
Division
75%
Surgery
50%
Bleeding
50%
Splenic Vein
50%
Overall Survival
25%
Clinical Trial
25%
Connective Tissue
25%
Malignant Neoplasm
25%
Recurrence Free Survival
25%
Celiac Artery
25%
Blood Flow
25%
Intention-to-Treat Analysis
25%
Retroperitoneal Lymph Node Dissection
25%
Lymph Flow
25%